Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas

Clinical trial NCT01960569 · UNKNOWN

Trial details

NCT number: NCT01960569
Sponsor: MinaPharm Pharmaceuticals
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

r-Hirudin (Thrombexx) Efficacy in Treatment of Haematomas

Start date: 2013-10-01
Primary completion: 2014-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.